VaxFact.net

Vaccine Database

Evidence-based profiles for 20 vaccines. Each page includes benefit-risk scoring, disease data, adverse events, credible scientific debates, and international policy comparisons.

RoutineAnnualShared DecisionTravel
🏥

Routine Childhood & Adult Vaccines

13 vaccines
🫀

Hepatitis B

Birth – 18 months (3-dose series)

Hepatitis B is a viral liver infection. In infants and young children, 90% of infections become chronic, leadi

99% vs severe disease44y in use
🫁

DTaP

2 months – 6 years (5-dose series)

DTaP prevents three distinct diseases. Diphtheria causes a throat membrane that can suffocate children — case

95% vs severe disease30y in use
🧠

Hib

2 months – 15 months (3–4 dose series)

Before the vaccine, Haemophilus influenzae type b was the leading cause of bacterial meningitis in children un

98% vs severe disease35y in use
🫀

PCV (Prevnar)

2 months – 15 months (4-dose series)

Streptococcus pneumoniae is a major cause of meningitis, sepsis, and pneumonia in children under 2. Before PCV

94% vs severe disease24y in use
🦠

MMR

12–15 months & 4–6 years (2-dose series)

Measles has an R0 of 12–18, making it the most contagious vaccine-preventable disease. Pre-vaccine USA: 3–4 mi

99% vs severe disease55y in use
🦠

Rotavirus

2 months – 8 months (oral series)

Rotavirus is the leading cause of severe diarrheal disease in infants and young children worldwide. Before vac

87% vs severe disease19y in use
💜

Varicella

12–15 months (dose 1); 4–6 years (dose 2)

Varicella-zoster virus causes chickenpox — a highly contagious illness with itchy blisters, fever, and malaise

98% vs severe disease30y in use
🟠

Hepatitis A

12–23 months (2-dose series); catch-up at any age

Hepatitis A virus (HAV) is a self-limiting liver infection. Unlike HepB, it does not cause chronic disease. Ho

99% vs severe disease30y in use
🎀

HPV

9–12 years (2-dose series); 15–26 years (3-dose series); up to 45 years (shared decision)

Human papillomavirus is the most common sexually transmitted infection — nearly all sexually active adults wil

97% vs severe disease18y in use
🔵

MenACWY

11–12 years (dose 1); 16 years (booster); infants 2–23 months if high-risk

Neisseria meningitidis causes two life-threatening presentations: meningitis (infection of the brain's protect

85% vs severe disease20y in use
👶

RSV Protection

Nirsevimab: all infants <8 months entering RSV season; maternal Abrysvo: 32–36 weeks gestation

RSV is the leading cause of infant hospitalization in the US — responsible for 58,000–80,000 hospitalizations

80% vs severe disease2y in use

Zoster (Shingrix)

50 years and older (2 doses); immunocompromised adults 19+

The same varicella-zoster virus (VZV) that causes childhood chickenpox lies dormant in nerve ganglia for life.

89% vs severe disease7y in use
💉

IPV (Polio)

2 months – 6 years (4-dose series); booster for adult travelers to endemic areas

Poliovirus causes irreversible paralysis by destroying motor neurons in the spinal cord. Before vaccination, p

99% vs severe disease70y in use
📅

Annual Vaccines

2 vaccines
💬

Shared Decision Vaccines

1 vaccines
✈️

Travel Vaccines

4 vaccines